Endocrine Abstracts

Background: Phthalates are currently used in medical devices, adhesives as plasticizers. Masculine reproductive toxicity is the greatest concern associated with exposure, known as the “phthalate syndrome”. The European Chemicals Agency has recognized di-butyl-phthalate (DBP, CAS 84-74-2) as an endocrine disruptor with deleterious effects on reproductive hormones, with an estimated human intake of 0.84-5.22 μg/kg/day. Effects reported include the disruption of Se...